Company Profiles

driven by the PitchBook Platform

Genkyotex

Genkyotex
2006 FOUNDED
PUBLIC STATUS
11-50 EMPLOYEES
Reverse Merger LATEST DEAL TYPE
$72.8M TOTAL AMOUNT RAISED
10 INVESTORS
Description

Developer of small molecule therapeutics that selectively inhibit NOX enzymes designed for the treatment of chronic diseases. The company engages in development of innovative drugs which block enzymes that produce oxygen radicals and allows the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.

Ownership Status
Publicly Held
Financing Status
Formerly VC-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
16, Chemin des Aulx
Plan - Les-Ouates
1228 Geneva
Switzerland

+41 (0)22 880 1025
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Genkyotex’s full profile, request a free trial.

Genkyotex Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Reverse Merger 28-Feb-2017 $72.8M Completed Generating Revenue
4. Later Stage VC (Series D) 07-Jan-2015 0000 000.00 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series C) 10-Jun-2012 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 06-May-2008 $3.82M $5.37M Completed Startup
1. Seed Round 30-Jan-2006 $1.55M $1.55M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Genkyotex Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioMedPartners Venture Capital Minority 000 0000 000000 0
Eclosion Ventures Accelerator/Incubator Minority 000 0000 000000 0
Edmond de Rothschild Investment Partners PE/Buyout Minority 000 0000 000000 0
Fondation d'Aide aux Entreprises Corporation Minority 000 0000 000000 0
MP Healthcare Venture Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Genkyotex Executive Team (11)

Name Title Board
Seat
Contact
Info
Elias Papatheodorou Chief Executive Officer & Board Member
Alexandre Grassin Director of Finance and Administration
Philippe Wiesel MD Chief Medical Officer & Executive Vice President
Karl-Heinz Krause MD Co-Founder & Board Member
Chihiro Yabe Co-Founder
You’re viewing 5 of 11 executives. Get the full list »

Genkyotex Board Members (15)

Name Representing Role Since Contact
Info
Claudio Nessi Ph.D NeoMed Management Board Member 000 0000
Diego Braguglia Ph.D VI Partners Board Observer 000 0000
Elias Papatheodorou Genkyotex Chief Executive Officer & Board Member 000 0000
Eric Viaud Self Board Observer 000 0000
Ernest Loumaye Ph.D Self Chairman 000 0000

3 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »